P300 KAT Regulates SOX10 Stability and Function in Human Melanoma

Overview

Journal Cancer Res Commun

Specialty Oncology

Date 2024 Jul 12

PMID 38994683

Authors

Aaron Waddell

Nicole Grbic

Kassidy Leibowitz

William Austin Wyant

Sabah Choudhury

Kihyun Park

Marianne Collard

Philip A Cole

Rhoda M Alani

Affiliations

Soon will be listed here.

Abstract

Significance: The p300 KAT inhibitor A-485 blocks SOX10-dependent proliferation and SOX10-independent invasion in hard-to-treat melanoma cells.

Citing Articles

Targeting lysine acetylation readers and writers.

Zhou M, Cole P Nat Rev Drug Discov. 2024; 24(2):112-133.

PMID: 39572658 PMC: 11798720. DOI: 10.1038/s41573-024-01080-6.

Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.

Wei E, Mitanoska A, OBrien Q, Porter K, Molina M, Ahsan H Mol Cancer. 2024; 23(1):222.

PMID: 39367409 PMC: 11453018. DOI: 10.1186/s12943-024-02115-7.

References

Vivas-Garcia Y, Falletta P, Liebing J, Louphrasitthiphol P, Feng Y, Chauhan J . Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity. Mol Cell. 2019; 77(1):120-137.e9. PMC: 7137507. DOI: 10.1016/j.molcel.2019.10.014. View

Marathe H, Watkins-Chow D, Weider M, Hoffmann A, Mehta G, Trivedi A . BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation. Nucleic Acids Res. 2017; 45(11):6442-6458. PMC: 5499657. DOI: 10.1093/nar/gkx259. View

Lehrer S, Rheinstein P . Predicted Configuration and Stability of the ATAD2/SOX10 Complex Using Molecular Dynamics Simulations. Cancer Diagn Progn. 2023; 3(3):398-402. PMC: 10165370. DOI: 10.21873/cdp.10231. View

Uka R, Britschgi C, Krattli A, Matter C, Mihic D, Okoniewski M . Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth. Oncogene. 2020; 39(20):4132-4154. PMC: 8076051. DOI: 10.1038/s41388-020-1267-7. View

Lv X, Wu W, Tang X, Wu Y, Zhu Y, Liu Y . Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration. Oncotarget. 2015; 6(34):36370-82. PMC: 4742183. DOI: 10.18632/oncotarget.5639. View

Fufa T, Harris M, Watkins-Chow D, Levy D, Gorkin D, Gildea D . Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes. Hum Mol Genet. 2015; 24(19):5433-50. PMC: 4572067. DOI: 10.1093/hmg/ddv267. View

Louphrasitthiphol P, Siddaway R, Loffreda A, Pogenberg V, Friedrichsen H, Schepsky A . Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution. Mol Cell. 2020; 79(3):472-487.e10. PMC: 7427332. DOI: 10.1016/j.molcel.2020.05.025. View

Yang D, Qu F, Cai H, Chuang C, Lim J, Jahchan N . Axon-like protrusions promote small cell lung cancer migration and metastasis. Elife. 2019; 8. PMC: 6940020. DOI: 10.7554/eLife.50616. View

Wu Y, Fletcher M, Gu Z, Wang Q, Costa B, Bertoni A . Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype. Nat Commun. 2020; 11(1):6434. PMC: 7749178. DOI: 10.1038/s41467-020-20225-w. View

10.

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

11.

Rosenbaum S, Tiago M, Caksa S, Capparelli C, Purwin T, Kumar G . SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects. Cell Rep. 2021; 37(10):110085. PMC: 8720266. DOI: 10.1016/j.celrep.2021.110085. View

12.

Kaufman C, Mosimann C, Fan Z, Yang S, Thomas A, Ablain J . A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science. 2016; 351(6272):aad2197. PMC: 4868069. DOI: 10.1126/science.aad2197. View

13.

Tang Y, Cao Y . Curcumin Inhibits the Growth and Metastasis of Melanoma via miR-222-3p/SOX10/Notch Axis. Dis Markers. 2022; 2022:3129781. PMC: 9110126. DOI: 10.1155/2022/3129781. View

14.

Capparelli C, Purwin T, Glasheen M, Caksa S, Tiago M, Wilski N . Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma. Nat Commun. 2022; 13(1):1381. PMC: 8927161. DOI: 10.1038/s41467-022-28801-y. View

15.

Waddell A, Huang H, Liao D . CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. Cancers (Basel). 2021; 13(12). PMC: 8229436. DOI: 10.3390/cancers13122872. View

16.

Tang Y, Durand S, Dalle S, Caramel J . EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment. Cancers (Basel). 2020; 12(8). PMC: 7465730. DOI: 10.3390/cancers12082154. View

17.

Cronin J, Watkins-Chow D, Incao A, Hasskamp J, Schonewolf N, Aoude L . SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res. 2013; 73(18):5709-18. PMC: 3803156. DOI: 10.1158/0008-5472.CAN-12-4620. View

18.

Yang S, Wei J, Cui Y, Park G, Shah P, Deng Y . mA mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019; 10(1):2782. PMC: 6592937. DOI: 10.1038/s41467-019-10669-0. View

19.

Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov J . Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011; 27(12):1739-40. PMC: 3106198. DOI: 10.1093/bioinformatics/btr260. View

20.

Wen Y, Xiong X, Zaytseva Y, Napier D, Vallee E, Li A . Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018; 9(3):265. PMC: 5833501. DOI: 10.1038/s41419-018-0330-6. View